Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Epigenetic regulation of melatonin receptors in neuropsychiatric disorders.

Bahna SG, Niles LP.

Br J Pharmacol. 2017 Oct 2. doi: 10.1111/bph.14058. [Epub ahead of print] Review.

PMID:
28967098
2.

Epigenetic induction of melatonin MT1 receptors by valproate: Neurotherapeutic implications.

Bahna SG, Niles LP.

Eur Neuropsychopharmacol. 2017 Aug;27(8):828-832. doi: 10.1016/j.euroneuro.2017.06.002. Epub 2017 Jun 22.

PMID:
28648552
3.

Bilateral upregulation of α-synuclein expression in the mouse substantia nigra by intracranial rotenone treatment.

Carriere CH, Kang NH, Niles LP.

Exp Toxicol Pathol. 2017 Feb;69(2):109-114. doi: 10.1016/j.etp.2016.12.007. Epub 2016 Dec 13.

PMID:
27986376
4.

Altered melatonin MT1 receptor expression in the ventral midbrain following 6-hydroxydopamine lesions in the rat medial forebrain bundle.

Kang NH, Carriere CH, Bahna SG, Niles LP.

Brain Res. 2016 Dec 1;1652:89-96. doi: 10.1016/j.brainres.2016.09.036. Epub 2016 Sep 28.

PMID:
27693415
5.

Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's disease.

Carriere CH, Kang NH, Niles LP.

Brain Res. 2016 Feb 15;1633:115-125. doi: 10.1016/j.brainres.2015.12.036. Epub 2015 Dec 29.

PMID:
26740407
6.

Epigenetic mechanisms of melatonin action in human SH-SY5Y neuroblastoma cells.

Pan Y, Niles LP.

Mol Cell Endocrinol. 2015 Feb 15;402:57-63. doi: 10.1016/j.mce.2015.01.003. Epub 2015 Jan 8.

PMID:
25578604
7.

Regional upregulation of hippocampal melatonin MT2 receptors by valproic acid: therapeutic implications for Alzheimer's disease.

Bahna SG, Sathiyapalan A, Foster JA, Niles LP.

Neurosci Lett. 2014 Jul 25;576:84-7. doi: 10.1016/j.neulet.2014.05.056. Epub 2014 Jun 5.

PMID:
24909617
8.

Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.

Carriere CH, Kang NH, Niles LP.

Neuroscience. 2014 May 16;267:114-21. doi: 10.1016/j.neuroscience.2014.02.028. Epub 2014 Mar 6.

PMID:
24613722
9.

Induction of neurotrophic and differentiation factors in neural stem cells by valproic acid.

Almutawaa W, Kang NH, Pan Y, Niles LP.

Basic Clin Pharmacol Toxicol. 2014 Aug;115(2):216-21. doi: 10.1111/bcpt.12201. Epub 2014 Feb 20.

10.

Melatonin induces histone hyperacetylation in the rat brain.

Niles LP, Pan Y, Kang S, Lacoul A.

Neurosci Lett. 2013 Apr 29;541:49-53. doi: 10.1016/j.neulet.2013.01.050. Epub 2013 Feb 13.

PMID:
23416321
11.

Resistin expression in human granulosa cells.

Niles LP, Lobb DK, Kang NH, Armstrong KJ.

Endocrine. 2012 Dec;42(3):742-5. doi: 10.1007/s12020-012-9734-8. Epub 2012 Jun 29. No abstract available.

PMID:
22744380
12.

HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation.

Yeung A, Bhargava RK, Ahn R, Bahna S, Kang NH, Lacoul A, Niles LP.

Biomed Pharmacother. 2012 Apr;66(3):232-6. doi: 10.1016/j.biopha.2011.06.007. Epub 2011 Aug 27.

PMID:
22436652
13.

Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain.

Niles LP, Sathiyapalan A, Bahna S, Kang NH, Pan Y.

Int J Neuropsychopharmacol. 2012 Oct;15(9):1343-50. doi: 10.1017/S1461145711001969. Epub 2012 Jan 16.

PMID:
22243807
14.

Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells.

Kim B, Rincón Castro LM, Jawed S, Niles LP.

Eur J Pharmacol. 2008 Jul 28;589(1-3):45-8. doi: 10.1016/j.ejphar.2008.04.058. Epub 2008 May 7.

PMID:
18550052
15.

Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells.

Sharma R, Ottenhof T, Rzeczkowska PA, Niles LP.

J Pineal Res. 2008 Oct;45(3):277-84. doi: 10.1111/j.1600-079X.2008.00587.x. Epub 2008 Mar 26.

PMID:
18373554
16.

Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease.

Sharma R, McMillan CR, Niles LP.

J Pineal Res. 2007 Oct;43(3):245-54.

PMID:
17803521
17.

Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells.

McMillan CR, Sharma R, Ottenhof T, Niles LP.

Neurosci Lett. 2007 Jun 4;419(3):202-6. Epub 2007 Apr 19.

PMID:
17482356
18.

Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation.

Jawed S, Kim B, Ottenhof T, Brown GM, Werstiuk ES, Niles LP.

Eur J Pharmacol. 2007 Mar 29;560(1):17-22. Epub 2007 Jan 23.

PMID:
17303109
19.

Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease.

Sharma R, McMillan CR, Tenn CC, Niles LP.

Brain Res. 2006 Jan 12;1068(1):230-6. Epub 2005 Dec 20.

PMID:
16375867
20.

Supplemental Content

Loading ...
Support Center